Haleon PLC (GB:HLN) has released an update. Haleon PLC has announced a change in major holdings as BlackRock, Inc. has adjusted its stake, now holding 5.17% of voting rights in the company. This ...
Acquisition of NRT business from Haleon, consolidation of Sanofi’s vaccine portfolio coupled with the launch of the Nutraceutical portfolio with Nestle in India and steady new launches across ...
Through its collaboration with Vistar Media and Publicis, Haleon will deliver personalised, data-driven out-of-home advertising across key international markets. According to a report by Adnews, ...
Global healthcare company Haleon has chosen Vistar Media as its preferred partner for programmatic out-of-home (OOH) across all key markets. Through this partnership, Vistar will collaborate with ...
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in ...
NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Haleon, a global leader in consumer healthcare, has chosen Vistar Media, the leading global provider of technology solutions for out-of-home (OOH ...
NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Haleon, a global leader in consumer healthcare, has chosen Vistar Media, the leading global provider of technology solutions for out-of-home (OOH) media, as ...
Haleon plc (LON:HLN) came out with its third-quarter results last week, and we wanted to see how the business is performing and what industry forecasters think of the company following this report ...
Haleon plc (LON:HLN) came out with its third-quarter results last week, and we wanted to see how the business is performing and what industry forecasters think of the company following this report.
Haleon PLC (GB:HLN) has released an update. Haleon PLC announced the allocation of share awards to its incoming CFO, Dawn Allen, under its Performance Share Plan and Share Value Plan. These awards ...
Oct 31 (Reuters) - Haleon (HLN.L), opens new tab missed third-quarter revenue and profit expectations on Thursday, hit by a stronger pound and lower sales of its painkiller Panadol in Australia ...